The difficulties of managing severe hepatitis B virus reactivation

  title={The difficulties of managing severe hepatitis B virus reactivation},
  author={B. Roche and D. Samuel},
  journal={Liver International},
  • B. Roche, D. Samuel
  • Published 2011
  • Medicine
  • Liver International
  • Reactivation of hepatitis B is characterized by a sudden increase in hepatitis B virus (HBV) replication in a patient with prior evidence of resolved or inactive HBV infection. Although HBV reactivation can occur spontaneously, it usually occurs after chemotherapy, immunosuppression (organ transplantation) or an alteration in immune function (therapy for autoimmune disease, human immunodeficiency virus infection). The clinical presentation cases can vary, ranging from a subclinical… CONTINUE READING
    63 Citations
    Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.
    • P. Puri
    • Medicine
    • Journal of clinical and experimental hepatology
    • 2013
    • 18
    Hepatitis B virus and hepatitis C virus treatment and management in patients receiving immune-modifying agents
    • 7
    Reactivation of Hepatitis B virus in kidney transplant recipients with previous clinically resolved infection: A single-center experience.
    • 2
    Patients with hematological malignancies and serological signs of prior resolved hepatitis B.
    • 10


    Managing HBV in patients with impaired immunity
    • 64
    Reactivation of hepatitis B in a long-term anti-HBs-positive patient with AIDS following lamivudine withdrawal.
    • 93
    HBV reactivation after kidney transplantation.
    • 58
    Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.
    • 149
    Hepatitis B in the HIV-Coinfected Patient
    • Y. Benhamou
    • Medicine
    • Journal of acquired immune deficiency syndromes
    • 2007
    • 57
    Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    • W. Yeo, T. C. Chan, +8 authors P. Chan
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2009
    • 552
    Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
    • 464
    • Highly Influential
    Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.
    • 792
    • Highly Influential